Low molecular weight heparin oral - Emisphere
Alternative Names: LMWH oralLatest Information Update: 14 Dec 2020
At a glance
- Originator Emisphere Technologies
- Class Low molecular weight heparins
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 08 Dec 2020 Emisphere Technologies has been acquired by Novo Nordisk
- 25 Feb 2004 This compound is still in active development
- 18 Jul 2003 Phase-I clinical trials in Thrombosis in USA (PO)